Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
EditorialEditor’s Page

Of Sheep and Wolves: Curtailing Coverage for Essential Imaging Tests Based on Flawed Use and Cost Arguments

Johannes Czernin, Martin Allen-Auerbach and Jeremie Calais
Journal of Nuclear Medicine December 2019, 60 (12) 1657-1658; DOI: https://doi.org/10.2967/jnumed.119.237636
Johannes Czernin
1Editor-in-Chief, JNM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Allen-Auerbach
2Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California; and
3Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
2Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California; and
3Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 12 1657-1658
DOI 
https://doi.org/10.2967/jnumed.119.237636
PubMed 
31792126

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online December 2, 2019.

Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging
    Johannes Czernin, Thaiza Adams, Jeremie Calais
    Journal of Nuclear Medicine 2022 63 7

Article usage

Article usage: December 2019 to April 2025

AbstractFullPdf
Dec 201939167115
Jan 20203913
Feb 2020596
Mar 2020163
Apr 2020242
May 2020140
Jun 202002411
Jul 202002518
Aug 20200128
Sep 20200222
Oct 20200137
Nov 20200114
Dec 202003312
Jan 202101811
Feb 202102011
Mar 20210259
Apr 20210187
May 20210188
Jun 20210203
Jul 202102717
Aug 202102111
Sep 20210254
Oct 202102426
Nov 202102523
Dec 20210297
Jan 20220363
Feb 20220216
Mar 20220158
Apr 202201181
May 20220188
Jun 20220274
Jul 20220205
Aug 20220187
Sep 202202312
Oct 20220137
Nov 202201610
Dec 20220101
Jan 20230198
Feb 20230189
Mar 20230123
Apr 20230184
May 20230169
Jun 20230145
Jul 20230145
Aug 2023084
Sep 20230153
Oct 20230165
Nov 20230168
Dec 20230350
Jan 20240213
Feb 20240115
Mar 202402420
Apr 202401817
May 20240256
Jun 20240176
Jul 202401111
Aug 202402710
Sep 20240187
Oct 202403113
Nov 20240156
Dec 20240165
Jan 20250822
Feb 202503215
Mar 202502114
Apr 202502725
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (12)
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Of Sheep and Wolves: Curtailing Coverage for Essential Imaging Tests Based on Flawed Use and Cost Arguments
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Of Sheep and Wolves: Curtailing Coverage for Essential Imaging Tests Based on Flawed Use and Cost Arguments
Johannes Czernin, Martin Allen-Auerbach, Jeremie Calais
Journal of Nuclear Medicine Dec 2019, 60 (12) 1657-1658; DOI: 10.2967/jnumed.119.237636

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Of Sheep and Wolves: Curtailing Coverage for Essential Imaging Tests Based on Flawed Use and Cost Arguments
Johannes Czernin, Martin Allen-Auerbach, Jeremie Calais
Journal of Nuclear Medicine Dec 2019, 60 (12) 1657-1658; DOI: 10.2967/jnumed.119.237636
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • More Unacceptable Denials: Now Its PSMA-Targeted PET/CT Imaging
  • Unacceptable Denials
  • Google Scholar

More in this TOC Section

  • Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
  • The Costs to Our Patients
  • Is ChatGPT a Reliable Ghostwriter?
Show more Editor’s Page

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire